Skip to main navigation
Skip to search
Skip to main content
University of Canberra Research Portal Home
Home
Profiles
Research output
Projects
Press/Media
Activities
Research units
Prizes
Student theses
Impacts
Search by expertise, name or affiliation
International Pharmaceutical Social Risk Regulation: An Ethical Perspective
Cameron Gordon
Canberra Business School
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Citation (Scopus)
51
Downloads (Pure)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'International Pharmaceutical Social Risk Regulation: An Ethical Perspective'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Ethical Attitude
100%
Risk Regulation
100%
Social Risk
100%
Pharmaceutical Manufacturing
50%
Rate of Return
25%
Europe
25%
Ethical Issues
25%
Big Business
25%
Social Action
25%
Developing World
25%
Drug Risk
25%
Government Regulation
25%
Manufacturing Enterprises
25%
Corporate Investment
25%
Pharmaceutical Distribution
25%
Drug Safety
25%
Drug Companies
25%
Government Oversight
25%
Dangerous Drugs
25%
Economics, Econometrics and Finance
Large Firm
100%
Developing World
100%
Ethical Issue
100%
Engineering
Developing Country
100%
Relative Importance
100%